Clinical Study to Assess Safety and Effectiveness of the Zenith® Dissection Endovascular System in Patients With Aortic Dissection

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

September 30, 2016

Conditions
Aortic Dissection Involving the Descending Thoracic Aorta
Interventions
DEVICE

Zenith® Dissection Endovascular System

The Zenith® Thoracic Dissection Study is a clinical trial to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of dissections (length-wise tear) of the descending thoracic aorta. The Zenith® Dissection Endovascular System is comprised of the Zenith TX2® TAA Endovascular Graft and the Zenith® Dissection Endovascular Stent. Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the graft and the dissection stent into place in the aorta.

DEVICE

Endovascular Repair

Endovascular Repair

Trial Locations (8)

18057

Clinic of Internal Medicine, University Hospital Rostock, Rostock

20129

Hospital San Raffaele, Milan

27100

IRCCS Policlinico San Matteo, Pavia

30625

Hannover Medical School, Hanover

59037

CHRU de Lille, Lille

VIC 3065

St. Vincent's Hospital Melbourne, Melbourne

656 91

St. Anne's Universtiy Hospital Brno, Brno

04289

Heart Center Leipzig / Park Hospital, Leipzig

All Listed Sponsors
collaborator

Cook Group Incorporated

INDUSTRY

collaborator

MED Institute, Incorporated

INDUSTRY

collaborator

William Cook Australia

INDUSTRY

lead

William Cook Europe

INDUSTRY

NCT00526487 - Clinical Study to Assess Safety and Effectiveness of the Zenith® Dissection Endovascular System in Patients With Aortic Dissection | Biotech Hunter | Biotech Hunter